Corneal Cross-Linking (CXL)

What is Keratoconus?

Keratoconus is a progressive eye condition that affects the structural integrity of the cornea—the clear, dome-shaped front surface of the eye. In patients with keratoconus, the corneal tissue gradually thins and bulges outward into an irregular cone-like shape, leading to visual distortion and frequent changes in vision.

Common symptoms of keratoconus include:

  • Blurred or Distorted Vision: Vision becomes progressively unclear, making standard activities like reading or driving difficult even with glasses.
  • Increased Glare and Light Sensitivity: Heightened photophobia in bright sunlight or around headlights at night.
  • Frequent Prescription Changes: Unstable changes in astigmatism or refractive error during routine eye exams.
  • Ghosting or Double Images: Objects may appear with faint secondary “ghost” outlines or halos.
  • Poor Night Vision: Significant visual reduction under low-light conditions.

The Next Generation of Care: Epioxa™ Replaces iLink™

For years, iLink™ served as the standard FDA-approved corneal cross-linking procedure. However, iLink required removing the top protective layer of the eye (epithelium-off), leading to longer healing times and temporary pain. iLink is now being phased out in favor of Epioxa™, an advanced epithelium-on (Epi-On) treatment designed to deliver effective structural reinforcement with a faster, much more comfortable recovery.

Why Epioxa™ is Taking Over for iLink™

Epithelium-On (Epi-On) Technology

Unlike iLink, which required scraping away the corneal epithelium, Epioxa utilizes specialized riboflavin formulations designed to penetrate directly through an intact outer layer.

Significantly Less Discomfort

Because the protective outer barrier remains intact, patients experience substantially less pain and discomfort during the early post-operative recovery period.

Faster Daily Recovery

Without a large open surface wound to heal, most patients can return to light daily routines within 24 to 48 hours following treatment.

Lower Infection Risk

Maintaining the continuous epithelial layer provides a natural defense against environmental bacteria, significantly reducing the risk of infection or corneal scarring.

How the Epioxa™ Procedure Works

Corneal cross-linking is designed to stiffen and stabilize the cornea to halt or slow the progression of keratoconus. While it does not reverse shape changes that have already occurred, it helps prevent further vision loss and minimizes the future need for invasive procedures like corneal transplants.

1 Numbing & Preparation

Anesthetic eye drops are applied to ensure complete comfort throughout the procedure. A gentle speculum is used to keep your eye open.

2 Epioxa™ Riboflavin Application

Specialized riboflavin drops (Vitamin B2) are applied directly to the surface of the eye. The solution soaks into the corneal stroma while leaving the surface epithelium intact.

3 Targeted UV-A Light Activation

Controlled ultraviolet-A (UV-A) light is applied to the cornea. The UV light interacts with the riboflavin to form new collagen cross-links (bonds) within the corneal tissue, reinforcing its strength and rigidity.

4 Post-Procedure Protection

Protective antibiotic and anti-inflammatory eye drops are applied. A soft bandage contact lens may be placed over the eye to support comfort during the initial hours.

Recovery and Aftercare

Because Epioxa leaves the corneal epithelium intact, the recovery process is much smoother than traditional iLink treatments.

What to Expect in the First Few Days

  • Mild Irritation: You may feel mild scratchiness, light sensitivity, or tearing for 24 to 48 hours, rather than the sharp pain associated with older epi-off techniques.
  • Medication Routine: Prescribed anti-inflammatory and antibiotic drops should be used exactly as directed by your surgeon.
  • Activity Restrictions: Avoid rubbing your eyes, swimming, or exposing your eyes to unsterile water (such as hot tubs) for at least one week post-procedure.
Vision Stabilization & Eyewear: Visual acuity may fluctuate slightly during the first few weeks after Epioxa. Once your cornea has fully stabilized (typically within 1 to 3 months), updated prescription glasses or specialized contact lenses (like scleral lenses) can be fitted to maximize your vision.

Insurance & Financial Options

Corneal cross-linking is widely recognized as medically necessary for progressive keratoconus and post-refractive ectasia. Our team works directly with insurance providers to confirm coverage and secure necessary pre-authorizations.